1. Home
  2. CRBP vs HQI Comparison

CRBP vs HQI Comparison

Compare CRBP & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.41

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

N/A

Current Price

$10.86

Market Cap

151.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBP
HQI
Founded
2009
2002
Country
United States
United States
Employees
N/A
65000
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
134.8M
151.0M
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
CRBP
HQI
Price
$9.41
$10.86
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$45.60
$13.00
AVG Volume (30 Days)
182.7K
11.1K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
2.21%
EPS Growth
N/A
N/A
EPS
N/A
0.34
Revenue
$4,822,272.00
$34,598,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$99.00
N/A
P/E Ratio
N/A
$31.88
Revenue Growth
97.62
N/A
52 Week Low
$4.64
$7.38
52 Week High
$20.56
$13.78

Technical Indicators

Market Signals
Indicator
CRBP
HQI
Relative Strength Index (RSI) 57.91 47.32
Support Level $8.80 $10.38
Resistance Level $9.69 $11.99
Average True Range (ATR) 0.62 0.70
MACD 0.21 -0.12
Stochastic Oscillator 62.75 27.60

Price Performance

Historical Comparison
CRBP
HQI

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

Share on Social Networks: